Caldwell Esselstyn repeatedly claims that extra virgin olive oil (EVOO) impairs flow mediated dilation (FMD) and endothelial function in arteries after consumption.
This is FALSE.
When you run a proper randomized controlled trial and actually test it in humans, EVOO improves both FMD and endothelial function immediately after ingestion, compared to baseline.
Quoted:
“EVOO acutely improved EF [endothelial function] as compared to refined olive oil (1.2 ± 6.5% versus −3.6 ± 3.8%; p = 0.0086).”
[Note that the numbers above in parentheses, 1.2 and -3.6, show the change in endothelial function relative to baseline after consuming EVOO and regular olive oil respectively.]
Quoted:
“Our data suggest that ingestion of a single dose of 50 mL of high-polyphenolic EVOO, compared with 50 mL of refined olive oil without polyphenols, improved FMD, a marker of cardiovascular risk, by an absolute improvement of 4.8% in adults at risk for T2DM. Based on EF [Endothelial Function] studies guidelines, an absolute improvement of as little as 1.5% in FMD is considered clinically significant [16]. Therefore, the FMD improvement observed was clinically meaningful and statistically significant.”
“Our data suggest that ingestion of high-polyphenolic EVOO, relative to refined olive oil without polyphenols, improved EF [Endothelial Function] among individuals at risk for T2DM. No acute effects on blood pressure were observed with either olive oil. Therefore, the inclusion of high-polyphenolic EVOO, rather than refined olive oil without polyphenols, in the diets of those at risk for T2DM may reduce their cardiovascular risk.”
Here is a link to the full journal paper:
PaperScienceDirect articlesciencedirect.com#evooHD #oliveoilHD #fmdHD #endothelialfunctionHD #esselstynHD #oliveoilfmdHD